Clinical

From hardcore peptide biochemist to translational scientist, it’s been an unconventional journey for Jennifer Van Eyk, Director of the Advanced Clinical Biosystems Research Institute at Cedars-Sinai Medical Center, Los Angeles. Here, Jenny tells us what she’s learnt along the way.

Cancer is incredibly complex, posing enormous challenges beyond the biological field. Taking a multi-omic approach can help us make sense of this diverse set of diseases – and, ultimately, allow us to better understand ourselves as human beings.

When it comes to microsampling for quantitative bioanalysis, the devil is certainly in the details. But we should learn from our mistakes – not retreat back into convention.

Near-infrared spectroscopy may allow non-invasive monitoring of premature babies

In this application note, a purified polyclonal antibody (IgG) is separated using Size Exclusion Chromatography (SEC) and characterized using the Viscotek SEC-MALS 20, allowing calculation of molecular weight and radius of gyration (Rg).

Can comprehensive two-dimensional gas chromatography breath analysis lead to better lung cancer diagnostics?

...the perfect companion to The Analytical Scientist.

Sitting Down With... Waseem Asghar, winner of the 2016 Humanity in Science Awards

For over 50 years, we have been continually striving to push the limits of quantitation for dioxins. But where do we stand today – and what’s our next plan of attack?

Ion chromatography uncovers a link between low iodine levels and symptoms of autism